Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review

Author:

Mudge Hannah R.1ORCID,Honey Jonathan R.2ORCID,Tachoukaft Sara3,Hider Samantha L.4ORCID,Mason Kayleigh J.4ORCID,Welsh Victoria K.4ORCID,Burton Claire4ORCID

Affiliation:

1. University of Southampton Southampton UK

2. Salisbury NHS Foundation Trust, Wessex Foundation School Salisbury UK

3. Anglia Ruskin University East Anglia UK

4. Keele University Keele UK

Abstract

ObjectiveMusculoskeletal symptoms are commonly reported following acute COVID‐19. It is unclear whether those with musculoskeletal symptoms subsequently develop inflammatory rheumatic musculoskeletal disease (iRMD). This review seeks to identify evidence for an association between acute COVID‐19 and subsequent iRMD diagnosis.MethodsA rapid review of the literature using a systematic search of Medline, EMBASE and two COVID‐19 databases was undertaken until August 2022. Case studies, case series, cross‐sectional, case‐control, and cohort studies reporting patients with an incident iRMD following COVID‐19 were included. Title and abstract screening were conducted by one reviewer and full text screening by two reviewers. Data extraction and quality appraisal were by one reviewer, with a second verifying. Study‐type specific critical appraisal tools were used.ResultsResults were narratively synthesized. A total of 80 studies were included (69 case reports, 10 case series and 1 cross‐sectional study). Commonly reported iRMDs were “reactive arthropathies” (n = 47), “inflammatory arthropathies unspecified” (n = 18), rheumatoid arthritis (n = 12) and systemic lupus erythematosus (n = 11). The cross‐sectional study reported 37% of those with COVID‐19 developed “post COVID arthritis.” Time from diagnosis of COVID‐19 to iRMD presentation ranged from 0 to 120 days. Several mechanisms were proposed to explain the association between COVID‐19 and iRMD development: autoimmune processes, aberrant inflammatory responses, colonization of joint spaces, direct damage from the severe acute respiratory syndrome coronavirus 2 virus and genetic predisposition.ConclusionThe level of evidence of the studies included in this review was low and the quality generally poor. Prospective observational studies are required to confirm associations and likely impact of post COVID‐19 iRMDs at a population level.

Funder

NIHR

Publisher

Wiley

Subject

Rheumatology

Reference101 articles.

1. World Health Organisation (WHO).Weekly epidemiological update on COVID‐19 ‐ 4January2023. Accessed XX.https://www.who.int/publications/m/item/weekly‐epidemiological‐update‐on‐covid‐19‐‐‐4‐january‐2023.

2. NICE Clinical Knowledge Summaries.NICE CKS long term effects of COVID‐19. Accessed XX.https://cks.nice.org.uk/topics/long‐term‐effects‐of‐coronavirus‐long‐covid/background‐information/definition/.

3. National Institute for Health and Care Excellence (NICE) Scottish Intercollegiate Guidelines Network (SIGN) Royal College of General Practitioners (RCGP).COVID‐19 rapid guideline: managing the longterm effects of COVID‐19. Accessed March 21 2023.https://www.nice.org.uk/guidance/ng188/resources/covid19‐rapid‐guideline‐managing‐the‐longterm‐effects‐of‐covid19‐pdf‐51035515742.

4. Office for National Statistics (ONS).Prevalence of ongoing symptoms following coronavirus (COVID‐19) infection in the UK. Accessed XX.https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/5january2023.

5. Characterising long COVID: a living systematic review

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3